AskTheDate.com
Back to calendar

Recursion Pharmaceuticals, Inc. (RXRX) Earnings

RXRX reports earnings on Monday, November 2, 2026

earnings report
November 2, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.20
Actual EPS: $-0.22
EPS surprise: -0.45%
Company overview
Market Cap$2.4B
PriceUSD 3.92
EPS (TTM)-0.89
52-week high5.24
52-week low2.77
SectorHealth Technology
IndustryBiotechnology
Employees600
Buy me a coffee